ARCHIVES

SPOREs In Breast, Prostate Cancers Win $12.7 Million.

This article is from The Cancer Letter archive.

Vol. 26 No. 36 | October 6, 2000

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Tobacco Industry Walkout Unlikely To Imperil Legislation

April 17, 1998

Nurses’ Work Environment Needs Change To Protect Patients From Errors, IOM Says

November 28, 2003

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

March 10, 1978

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976